Aims: SCN5A is a disease-causing gene associated with familial dilated cardiomyopathy (FDC). We examined the possible association between a common polymorphism in the SCN5A gene (c.1673A>G-p.H558R; rs1805124) and the risk of dilated cardiomyopathy (DCM) occurrence.
Methods: We genotyped 185 DCM cases (familial DCM, idiopathic DCM and postischemic DCM) and 251 controls for the p.H558R polymorphism in the SCN5A gene, to test the association of the molecular epidemiology of the individuals with the presence/absence of various types of DCM.
Results: Our results showed that the rs1805124 polymorphism was significantly associated with DCM, and the association was more significant in patients with FDC; furthermore, in these individuals, the less frequent GG genotype was associated with a 7.39-fold increased risk of disease [95% confidence interval (95% CI) = 2.88-18.96; P < 0.0001] compared with the AA genotype. Moreover, logistic regression analysis showed that GG carriers had a higher risk of DCM than AA + AG carriers (odds ratio = 5.45, 95% CI = 2.23-13.35; P < 0.001). No association was observed between the rs1805124 and DCM risk in postischemic DCM patients.
Conclusion: Our study demonstrates an association between familial DCM and the rs1805124 polymorphism in the SCN5A gene, which may unravel additional genetic predisposition to the development of a multifactorial disease as DCM.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6012048 | PMC |
| http://dx.doi.org/10.2459/JCM.0000000000000670 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
The impact of common and rare genetic variants on bradyarrhythmia development.
Nat Genet
January 2025
Telemachus and Irene Demoulas Family Foundation Center for Cardiac Arrhythmias, Massachusetts General Hospital, Boston, MA, USA.
To broaden our understanding of bradyarrhythmias and conduction disease, we performed common variant genome-wide association analyses in up to 1.3 million individuals and rare variant burden testing in 460,000 individuals for sinus node dysfunction (SND), distal conduction disease (DCD) and pacemaker (PM) implantation. We identified 13, 31 and 21 common variant loci for SND, DCD and PM, respectively.
View Article and Find Full Text PDFCopy Number Variants in Cardiac Channelopathies: Still a Missed Part in Routine Arrhythmic Diagnostics.
Biomolecules
November 2024
Cardiogenetic Center, Rare Diseases and Medical Genetics Units, Bambino Gesù Children's Hospital, IRCCS, 00165 Rome, Italy.
Inherited cardiac channelopathies are major causes of sudden cardiac death (SCD) in young people. Genetic testing is focused on the identification of single-nucleotide variants (SNVs) by Next-Generation Sequencing (NGS). However, genetically elusive cases can carry copy number variants (CNVs), which need specific detection tools.
View Article and Find Full Text PDFGeneration of two induced pluripotent stem cell (iPSC) lines carrying the Brugada Syndrome-associated mutation SCN5A-R282H.
Stem Cell Res
December 2024
Department of Anatomy and Embryology, Leiden University Medical Center, 2300RC Leiden, the Netherlands. Electronic address:
Article Synopsis
- Brugada Syndrome (BrS) is a serious heart condition that can cause sudden cardiac death and is linked to mutations in the SCN5A gene, which affects sodium channels in the heart.
- Researchers created human induced pluripotent stem cell (hiPSC) lines with a specific BrS mutation (c.845G>A or p.R282H) to better understand its effects.
- The study compares two hiPSC lines: one with the mutation on the same gene copy as another polymorphism (c.1673A>G or p.H558R) and one with it on the opposite gene copy, providing a model to investigate their physiological impacts.
Prevalence and relevance of H558R in the efficacy and toxicity of flecainide in patients with atrial fibrillation: a cohort study.
Heart
January 2025
Cardiology, Hospital Clínico Universitario de Santiago de Compostela Servicio de Cardiología, Santiago De Compostela, A Coruña, Spain.
Background: The SCN5A gene polymorphism histidine-558-to-arginine (H558R) has been associated with atrial fibrillation (AF) and may affect the therapeutic effects of flecainide. This study aimed to assess the prevalence of the H558R polymorphism in a European cohort of patients with AF and examine its association with flecainide's effects on AF recurrence and toxicity.
Methods: This cohort study included patients diagnosed with AF and prescribed flecainide between 2017 and 2021 in a regional health area.
Nonmodifiable Risk Factors Predict Outcomes in Brugada Syndrome.
J Am Coll Cardiol
November 2024
Molecular Cardiology Unit, IRCCS Istituti Clinici Scientifici Maugeri, Pavia, Italy; Department of Molecular Medicine, University of Pavia, Pavia, Italy. Electronic address:
Article Synopsis
- This study investigates nonmodifiable risk factors for life-threatening arrhythmic events (LAEs) in patients with Brugada syndrome (BrS), focusing on factors like sex and genetic mutations.
- Data was collected from over 2,000 Italian patients with BrS, revealing that male sex and specific SCN5A gene mutations significantly increase the risk of experiencing LAEs.
- The findings suggest that certain nonmodifiable risks can help stratify patients into different risk profiles, aiding in the management and prognostication of BrS.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!